Skip to main content

Mechanisms of Action of Antiarrhythmic Drugs in Ventricular Arrhythmias

  • Chapter
  • First Online:
Electrical Diseases of the Heart

Abstract

Most antiarrhythmic drugs act on ion channels and alter the electrical properties of cardiac ­tissues, which is beneficial for preventing or treating cardiac arrhythmias. This chapter provides a basic understanding of anti-arrhythmic agents, especially on the electrophysiological properties of cardiac excitation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Vaughan Williams EM. A classification of antiarrhythmic actions reassessed after a decade of new drugs. J Clin Pharmacol. 1984;24:129–47.

    Article  PubMed  CAS  Google Scholar 

  2. Vaughan Williams EM. Classification of antiarrhythmic drugs. In: Sandoe E, Flensted-Jensen E, Olsen EH, editors. Symposium on cardiac arrhythmias. Sodertalje: AB Astra; 1970. p. 449–501.

    Google Scholar 

  3. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. The Sicilian Gambit: a new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Circulation. 1991;84:1831–51.

    Article  Google Scholar 

  4. Hondeghem LM, Katzung BG. Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels. Biochim Biophys Acta. 1977;472:373–98.

    Article  PubMed  CAS  Google Scholar 

  5. Hille B. Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction. J Gen Physiol. 1977;69:497–515.

    Article  PubMed  CAS  Google Scholar 

  6. Belardinelli L, Antzelevitch C, Vos MA. Assessing predictors of drug-induced torsade de pointes. Trends Pharmacol Sci. 2003;2412:619–25.

    Article  Google Scholar 

  7. Zeng J, Laurita KR, Rosenbaum DS, Rudy Y. Two components of the delayed rectifier K+ current in ventricular myocytes of the guinea pig type. Theoretical formulation and their role in repolarization. Circ Res. 1995;77:140–52.

    Article  PubMed  CAS  Google Scholar 

  8. Lerman BB, Belardinelli L, West GA, Berne RM, DiMarco JP. Adenosine-sensitive ventricular tachy­cardia: evidence suggesting cyclic AMP-mediated triggered activity. Circulation. 1986;74:270–80.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yoshihisa Kurachi MD, PhD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag London

About this chapter

Cite this chapter

Murakami, S., Kurachi, Y. (2013). Mechanisms of Action of Antiarrhythmic Drugs in Ventricular Arrhythmias. In: Gussak, I., Antzelevitch, C. (eds) Electrical Diseases of the Heart. Springer, London. https://doi.org/10.1007/978-1-4471-4881-4_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-4881-4_7

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-4880-7

  • Online ISBN: 978-1-4471-4881-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics